Efficacy of ultrasound-guided pectoral nerve block in reducing tumor recurrence and metastasis related serum factors in breast cancer surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032647

Enrollment

Unknown

Registered

2020-05-04

Start date

2020-07-01

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

experimental group:ultrasound-guided Pectoral nerve block

control group:General anesthesia alone

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Women with unilateral breast cancer surgery, aged 18-65 years, ASA 1-3.

Exclusion criteria

Exclusion criteria: Severe heart, lung, liver and kidney dysfunction, coagulation dysfunction, skin infection and ulceration at nerve block site, diabetes mellitus, nervous system disease, etc..

Design outcomes

Primary

Measure	Time frame
Vascular endothelial growth factor C;Transforming growth factor ß;Natural killer cell;	—

Countries

China

Contacts

Public ContactLiu Tianxiao

Traditional Chinese Medicine Hospital of Guilin City

liutxdoctor@qq.com+86 18978690330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026